Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to 2.02.

  • Zevra Therapeutics' Interest Coverage Ratio rose 11710.33% to 2.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 10.66, marking a year-over-year increase of 2732.1%. This contributed to the annual value of 11.84 for FY2024, which is 6418.61% up from last year.
  • Latest data reveals that Zevra Therapeutics reported Interest Coverage Ratio of 2.02 as of Q3 2025, which was up 11710.33% from 35.36 recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Interest Coverage Ratio registered a high of 364.56 during Q2 2021, and its lowest value of 689.31 during Q2 2022.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 31.74 (2023), whereas its average is 103.52.
  • Over the last 5 years, Zevra Therapeutics' Interest Coverage Ratio had its largest YoY gain of 1672920.6% in 2021, and its largest YoY loss of 3540681.51% in 2021.
  • Zevra Therapeutics' Interest Coverage Ratio (Quarter) stood at 568.4 in 2021, then skyrocketed by 90.54% to 53.78 in 2022, then soared by 62.72% to 20.05 in 2023, then surged by 64.95% to 7.03 in 2024, then soared by 128.75% to 2.02 in 2025.
  • Its last three reported values are 2.02 in Q3 2025, 35.36 for Q2 2025, and 2.72 during Q1 2025.